switching tirzepatide to semaglutide from Semaglutide: What to Expect What Happens When You Switch

The synergistic activation of GIP and GLP-1 receptors has been recognized as a promising therapeutic approach in the treatment of T2D and obesity (17, 18)

The postpartum period comes with its own unique challenges, and healthy weight loss often looks different than it did before pregnancy

Taking doses too frequently can increase the risk of severe side effects without providing additional weight loss benefits

Goal: moderate weight loss (10 to 15% of body weight) If your target is 10 to 15% body weight reduction, you may not need to escalate beyond 4 to 8 mg

One major issue is difficulty in attributing mechanisms: It remains unclear whether their neuroprotective effects arise specifically from ferroptosis inhibition or indirectly through anti-inflammatory, anti-aggregation, or mitochondrial protective pathways, and genetic evidence is lacking (e.g., validation in GPX4 conditional knockout models)